Literature DB >> 8998197

The role of angiotensin II and prostaglandins in arcade formation in a developing microvascular network.

F A le Noble1, L C Kessels-van Wylick, W J Hacking, D W Slaaf, M G oude Egbrink, H A Struijker-Boudier.   

Abstract

There are basically two types of branching patterns in the terminal part of the arteriolar tree. On the one hand, in a number of tissues, including the developing chick embryo chorioallantoic membrane (CAM), the pattern is dichotomous, whereas in other tissues many arteriolar-arteriolar connections, arcades, are found. The structure of the branching pattern depends on the local physical and chemical environment. The goal of this study was to investigate whether substances with an effect on vascular growth influence the vascular branching pattern. We treated chick embryo CAMs daily from day 7 to day 14 postfertilization with 0.9% NaCl, angiotensin II (ANG-II), ANG-II in combination with different angiotensin receptor subtype antagonists, i.e., losartan and CGP 42112A, or the prostaglandin synthesis inhibitor acetylsalicylic acid (ASA). Arcade formation was quantified by counting the number of arcades per cm2 treated area, the branch-node ratio and mean surface area of arcade loops. ANG-II caused a 2-fold increase in the number of arcades versus 0.9% NaCl. Addition of ASA or losartan caused a further enhancement of arcade formation expressed in the number and branch-node ratio. CGP 42112A had no significant effect on arcade formation. From these data we hypothesize that ANG-II stimulates the process of capillary upgrading to arterioles by stimulation of arteriolar smooth muscle cell growth. Prostaglandins normally counteract this effect. After blockade of prostaglandin action, the ANG-II-induced arterialization is enhanced, resulting in pronounced arcade formation. The actions of losartan may be related to its inhibitory effects on prostaglandins rather than angiotensin receptor antagonism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8998197     DOI: 10.1159/000159187

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  6 in total

1.  Intracellular Angiotensin II and cell growth of vascular smooth muscle cells.

Authors:  C M Filipeanu; R H Henning; D de Zeeuw; A Nelemans
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice.

Authors:  Susumu Ishiguro; Kiyoshi Yoshimura; Ryouichi Tsunedomi; Masaaki Oka; Sonshin Takao; Makoto Inui; Atsushi Kawabata; Terrahn Wall; Vassiliki Magafa; Paul Cordopatis; Andreas G Tzakos; Masaaki Tamura
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Angiotensinogen impairs angiogenesis in the chick chorioallantoic membrane.

Authors:  Marcus Brand; Noël Lamandé; Etienne Larger; Pierre Corvol; Jean-Marie Gasc
Journal:  J Mol Med (Berl)       Date:  2006-12-16       Impact factor: 4.599

4.  Angiotensin II is a growth factor in the peri-implantation rat embryo.

Authors:  C Tebbs; M K Pratten; F Broughton Pipkin
Journal:  J Anat       Date:  1999-07       Impact factor: 2.610

Review 5.  Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen.

Authors:  Pierre Corvol; Noel Lamandé; Amauri Cruz; Jerome Celerier; Jean-Marie Gasc
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

6.  Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer.

Authors:  Sarah Ruderman; Adam Eshein; Vesta Valuckaite; Urszula Dougherty; Anas Almoghrabi; Andrew Gomes; Ajaypal Singh; Baldeep Pabla; Hemant K Roy; John Hart; Marc Bissonnette; Vani Konda; Vadim Backman
Journal:  BMC Cancer       Date:  2018-08-13       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.